Stock Events

Stock Events

Iovance Biotherapeutics (0JDK.LSE) Q2 2024 Earnings

9MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.45

-0.44

-0.43

-0.42

Details

Expected EPS

-0.424345

Actual EPS

-0.42

Surprise EPS

0

Surprise Percent

+1.02%

Description

Iovance Biotherapeutics (0JDK.LSE) has reported earnings of -0.42 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.